latanoprost
Selected indexed studies
- Latanoprost and pigmentation. (Jpn J Ophthalmol, 2004) [PMID:15592791]
- Latanoprost versus combined timolol and dorzolamide. (Surv Ophthalmol, 2002) [PMID:12204712]
- [Long-term use of latanoprost in the treatment of glaucoma]. (Vestn Oftalmol, 2020) [PMID:32366080]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Latanoprost and pigmentation. (2004) pubmed
- Latanoprost versus combined timolol and dorzolamide. (2002) pubmed
- [Long-term use of latanoprost in the treatment of glaucoma]. (2020) pubmed
- Latanoprost as a new horizon in the medical management of glaucoma. (1996) pubmed
- Latanoprost for the treatment of pediatric glaucoma. (2002) pubmed
- Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension. (2020) pubmed
- Latanoprost : an update of its use in glaucoma and ocular hypertension. (2003) pubmed
- Latanoprost-induced Skin Depigmentation. (2017) pubmed
- Latanoprost and cholinergic agonists in combination. (2002) pubmed
- Latanoprost and cystoid macular edema: is there a causal relation? (2000) pubmed